FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.16  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.22.0 (94 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1116.81/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81
Version 20241211
Status active
Date 2024-12-11T01:13:08-05:00
Name PalonosetronOral
Title Palonosetron Oral
Experimental False
Realm us
Authority hl7
Purpose (Clinical Focus: The purpose of this value set is to represent concepts of medication Palonosetron.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Palonosetron; generic; prescribable; oral.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm


Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1116.81",
  "meta" : {
    "versionId" : "25",
    "lastUpdated" : "2024-12-11T01:13:08.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "American Society of Clinical Oncology Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-12-11"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-12-11"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1116.81"
    }
  ],
  "version" : "20241211",
  "name" : "PalonosetronOral",
  "title" : "Palonosetron Oral",
  "status" : "active",
  "date" : "2024-12-11T01:13:08-05:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication Palonosetron.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Palonosetron; generic; prescribable; oral.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "805448",
            "display" : "palonosetron 0.5 MG Oral Capsule"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:9934e08e-9a83-4ea1-a544-a25f6f3954b5",
    "timestamp" : "2025-05-11T03:41:28-04:00",
    "total" : 0
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.